Recombinant Human TACI/TNFRSF13B/CVID Protein
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-61308
Key Product Details
Source
E. coli
Conjugate
Unconjugated
Applications
Bioactivity, Western Blot
Product Specifications
Description
A single non-glycosylated polypeptide chain containing 160 amino acids corresponding to TACI/TNFRSF13B/CVID Source: E. coli
Uniprot ID: O14836
Amino Acid Sequence: MSGLGRSRRG GRSRVDQEER FPQGLWTGVA MRSCPEEQYW DPLLGTCMSC KTICNHQSQR TCAAFCRSLS CRKEQGKFYD HLLRDCISCA SICGQHPKQC AYFCENKLRS PVNLPPELRR QRSGEVENNS DNSGRYQGLE HRGSEASPAL PGLKLSADQV
Purity
>95%, by SDS-PAGE and HPLC
Endotoxin Level
Less than 1 EU/ug of TACI/TNFRSF13B/CVID as determined by LAL method.
Predicted Molecular Mass
18 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Activity
Fully biologically active when compared to standard. The biological activity is determined by its ability to block human BAFF induced T2B cell survival using a concentration range of 1.0-3.0 ug/ml.
Protein / Peptide Type
Recombinant Protein
Scientific Data Images for Recombinant Human TACI/TNFRSF13B/CVID Protein
![SDS-PAGE: Recombinant Human TACI/TNFRSF13B/CVID Protein [NBP2-61308]](https://resources.bio-techne.com/images/products/Recombinant-Human-TACI-TNFRSF13B-CVID-Protein-SDS-Page-NBP2-61308-img0002.jpg "SDS-PAGE: Recombinant Human TACI/TNFRSF13B/CVID Protein [NBP2-61308]")
SDS-PAGE: Recombinant Human TACI/TNFRSF13B/CVID Protein [NBP2-61308]
SDS-Page: Recombinant Human TACI/TNFRSF13B/CVID Protein [NBP2-61308]Formulation, Preparation and Storage
NBP2-61308
| Formulation | Lyophilized from a 0.2 um filtered concentrated solution in PBS, pH 7.4. |
| Preservative | No Preservative |
| Concentration | Lyoph |
| Reconstitution | Recommended to centrifuge prior to opening. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0mg/mL. Apportion stock solutions into working aliquots and store at |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Store at -20 to -70C as supplied. After reconstitution, store at 2 to 8C for 1 month and at -20 to -70C for long term storage. Avoid repeated freeze-thaw cycles. |
Background: TACI/TNFRSF13B
Long Name
Transmembrane Activator and CAML Interactor/Tumor Necrosis Factor Receptor Superfamily Member 13B
Alternate Names
CD267, CVID, TNFRSF13B
Gene Symbol
TNFRSF13B
Additional TACI/TNFRSF13B Products
Product Documents for Recombinant Human TACI/TNFRSF13B/CVID Protein
Product Specific Notices for Recombinant Human TACI/TNFRSF13B/CVID Protein
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...